Aptevo Therapeutics (APVO) Interest Coverage Ratio (2015 - 2026)
Aptevo Therapeutics (APVO) posted Interest Coverage Ratio of 19.88 for Q1 2026, down 61.09% sequentially from 12.34 in Q4 2025, and down 5.51% YoY from 21.03 in Q1 2025.
Aptevo Therapeutics (APVO) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Aptevo Therapeutics has reported Interest Coverage Ratio for 12 years, with the latest figure at 19.88 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 5.51% year-over-year to 19.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 77.53 (down 10.66% YoY) and the FY2025 annual result came in at 4.41, down 31.63% from the prior year.
- Interest Coverage Ratio fell to 19.88 in Q1 2026 per APVO's latest filing, from 12.34 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 4.64 in Q4 2024 and troughed at 67.44 in Q1 2023.
- A 5-year average of 15.0 and a median of 9.99 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio tumbled 994.69% in 2022, then jumped 69.9% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 8.59 in 2022, then surged by 35.17% to 5.57 in 2023, then grew by 16.67% to 4.64 in 2024, then tumbled by 166.0% to 12.34 in 2025, then plunged by 61.09% to 19.88 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 19.88, 12.34, and 7.37 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 1.42 |
| 10 | Aptevo Therapeutics | 3.17 Mn | -6.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.36 |
| Mar 31, 2026 | -19.88 |
| Dec 31, 2025 | -12.34 |
| Sep 30, 2025 | -7.37 |
| Jun 30, 2025 | -9.05 |
| Mar 31, 2025 | -18.84 |
| Dec 31, 2024 | -4.64 |
| Sep 30, 2024 | -5.05 |
| Jun 30, 2024 | -8.76 |
| Mar 31, 2024 | -20.30 |
| Dec 31, 2023 | -5.57 |
| Sep 30, 2023 | -8.17 |
| Jun 30, 2023 | -17.82 |
| Mar 31, 2023 | -67.44 |
| Dec 31, 2022 | -8.59 |
| Sep 30, 2022 | -9.99 |
| Jun 30, 2022 | -13.82 |
| Mar 31, 2022 | -17.37 |
| Sep 30, 2021 | -3.78 |
| Jun 30, 2021 | -2.09 |